Prevalence of Neonatal Hypoxia in District Buner, Pakistan
DOI:
https://doi.org/10.61919/jhrr.v4i1.414Keywords:
Neonatal Hypoxia, Hypoxic Ischemic Encephalopathy, Prevalence, District Buner, Neonatal Morbidity, Neonatal MortalityAbstract
Background: Neonatal hypoxia, or hypoxic ischemic encephalopathy (HIE), is a significant cause of neonatal morbidity and mortality, especially in developing countries. The condition arises from insufficient oxygen or blood flow to the neonate's brain, leading to various degrees of neurological impairment. This study aims to shed light on the prevalence and characteristics of neonatal hypoxia in District Buner, Khyber Pakhtunkhwa, Pakistan, a region where limited research has been conducted on this critical issue.
Objective: The primary objective of this study was to determine the prevalence of neonatal hypoxia in District Buner and to analyse the distribution of its severity across different tehsils within the district.
Methods: This retrospective study was conducted from August 2021 to August 2022. Data were collected from several government and private hospitals, including DHQ Daggar, Buner Medical Complex, and Hamdard Medical Center. A total of 753 neonatal hypoxia cases were identified and classified into three categories based on severity: mild (HIE I), moderate (HIE II), and severe (HIE III). The classification was based on Apgar scores and clinical symptoms. The data were statistically analysed using Microsoft Excel 2016 and SPSS software version 25.
Results: Out of the 753 neonatal hypoxia cases, 299 (39.7%) were classified as HIE I, 276 (36.6%) as HIE II, and 132 (17.5%) as HIE III. There were 46 fatalities (6.1%) reported. The study also revealed a gender disparity, with males (402 cases, 53.4%) more frequently affected than females (351 cases, 46.6%). The highest incidence of neonatal hypoxia was observed in Tehsil Daggar (25.9%), while Tehsil Khudokhail reported the lowest (6.2%).
Conclusion: The study highlights a significant prevalence of neonatal hypoxia in District Buner, with milder forms of HIE being more common. The findings underscore the need for improved obstetric and neonatal care, especially in areas with higher prevalence, to reduce neonatal morbidity and mortality associated with HIE.
Downloads
References
Ahmad QM, Chishti AL, Waseem N. Role of melatonin in management of hypoxic ischaemic encephalopathy in newborns: A randomized control trial. JPMA The Journal of the Pakistan Medical Association. 2018;68(8):1233-7.
Acun C, Karnati S, Padiyar S, Puthuraya S, Aly H, Mohamed M. Trends of Neonatal Hypoxic-Ischemic Encephalopathy Prevalence and Associated Risk Factors in the United States, 2010 to 2018. Obstetrical & Gynecological Survey. 2023;78(5):257-9.
AlMuqbil M, Alanazi J, Alsaif N, Baarmah D, Altwaijri W, Alrumayyan A, et al. Clinical Characteristics and Risk Factors of Neonatal Hypoxic-Ischaemic Encephalopathy and Its Associated Neurodevelopmental Outcomes During the First Two Years of Life: A Retrospective Study in Saudi Arabia. International Journal of General Medicine. 2023:525-36.
Oorschot DE, Sizemore RJ, Amer AR. Treatment of neonatal hypoxic-ischemic encephalopathy with erythropoietin alone, and erythropoietin combined with hypothermia: history, current status, and future research. International journal of molecular sciences. 2020;21(4):1487.
Nair J, Kumar VH. Current and emerging therapies in the management of hypoxic ischemic encephalopathy in neonates. Children. 2018;5(7):99.
Malik FR, Amer K, Ullah M, Muhammad AS. Why our neonates are dying? Pattern and outcome of admissions to neonatal units of tertiary care hospitals in Peshawar from January, 2009 to December, 2011. JPMA. 2016;66(40).
Ayele GM, Mergia G, Getahun SB, Kebede SS, Ferede ZA, Kabthymer RH, et al. Hypoxic-Ischemic Encephalopathy Based on clinical biomarkers and associated risk factors in Neonates from Southern Ethiopian Public Hospitals: A Case Control Study. medRxiv. 2023:2023.05. 28.23290654.
Batra P, Singh P, Ahmed R, Harit D. Serum Vitamin D status in full term neonates with severe perinatal depression. Journal of Neonatal-Perinatal Medicine. 2023(Preprint):1-8.
Bharathi M, Madhu A, Murthy S, Sandhya D, Kavya S. Assessment of Otoacoustic Emissions (OAE) in Birth Asphyxiated Neonates. Indian Journal of Otolaryngology and Head & Neck Surgery. 2023;75(Suppl 1):38-42.
Wang Q, Lv H, Lu L, Ren P, Li L. Neonatal hypoxic–ischemic encephalopathy: Emerging therapeutic strategies based on pathophysiologic phases of the injury. The Journal of Maternal-Fetal & Neonatal Medicine. 2019;32(21):3685-92.
Buccione E, Chiavaroli V, Fornaro DS, Toracchio E, Cicioni P, Rasero L, et al. Bladder Temperature During Neonatal Targeted Temperature Management: A Case Report. Advances in Neonatal Care. 2023;23(5):418-24.
Cornet M-C, Kuzniewicz M, Scheffler A, Forquer H, Hamilton E, Newman TB, et al. Perinatal Hypoxic-Ischemic Encephalopathy: Incidence Over Time Within a Modern US Birth Cohort. Pediatric Neurology. 2023;149:145-50.
Hameed M, Bozdar H, Khurshid S, Sohail H, Siddiqui F, Fatima N, et al. Prevalence, and Pattern of Hypoxic Ischemic Encephalopathy on Magnetic Resonance Imaging among Pediatric patients. Pakistan Journal of Medical & Health Sciences. 2023;17(03):10-.
Labat J, Brocard C, Belaroussi Y, Bar C, Gotchac J, Chateil J-F, et al. Hypothermia for neonatal hypoxic–ischemic encephalopathy: Retrospective descriptive study of features associated with poor outcome. Archives de Pédiatrie. 2023;30(2):93-9.
Lan X-B, Ni Y-S, Liu N, Wei W, Liu Y, Yang J-M, et al. Neuroprotective effects of oxymatrine on hypoxic–ischemic brain damage in neonatal rats by activating the Wnt/β-catenin pathway. Biomedicine & Pharmacotherapy. 2023;159:114266.
Mwatonoka JF, Jumanne S, Nyundo A, Kruger C. High incidence of poor in‐hospital outcomes of term newborns with hypoxic–ischaemic encephalopathy admitted at a regional referral hospital in Dodoma, Tanzania. Acta Paediatrica. 2023;112(8):1774-82.
Pandya F, Mukherji A, Goswami I. An Exploratory Analysis of Gastrointestinal Morbidities and Feeding Outcomes Associated with Neonatal Hypoxic–Ischemic Encephalopathy With or Without Hypothermia Therapy. Therapeutic Hypothermia and Temperature Management. 2023.
Parc E, Benin A, Lecarpentier E, Goffinet F, Lepercq J. Risk factors for hypoxic-ischemic encephalopathy or neonatal death in placental abruption. Journal of Gynecology Obstetrics and Human Reproduction. 2023;52(1):102498.
Park J, Park SH, Kim C, Yoon SJ, Lim JH, Han JH, et al. The growth and developmental outcomes of Hypoxic Ischemic Encephalopathy; Population-based study from 2010 to 2019. 2023.
Ranjan AK, Gulati A. Advances in therapies to treat neonatal hypoxic-ischemic encephalopathy. Journal of Clinical Medicine. 2023;12(20):6653.
Strauss E, Gotz-Więckowska A, Sobaniec A, Chmielarz-Czarnocińska A, Szpecht D, Januszkiewicz-Lewandowska D. Hypoxia-Inducible Pathway Polymorphisms and Their Role in the Complications of Prematurity. Genes. 2023;14(5):975.
Tzeli M, Tigka M, Pantelaki N, Lazarou E, Metallinou D. Future perspectives on neonatal brain injury. 2023.
Venkatakrishna SSB, Elsingergy M, Worede F, Curic J, Andronikou S. Unequal cerebral magnetic resonance imaging changes in perinatal hypoxic ischemic injury of term neonates. Journal of computer assisted tomography. 2023;47(6):913-8.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Hameed Khan, Muhammad Asif, Muhammad Razaq, Amina Rahat, Yasin Kayani, Tahir Azeem, Hasnain Zafar, Hameed Ur Rehman, Imad Ali Khan, Said Amir Shah, Kausar Saeed
This work is licensed under a Creative Commons Attribution 4.0 International License.
